• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-4 和白细胞介素-10 驱动标志物在内脏利什曼病实验模型中的状态。

Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.

机构信息

Department of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, India.

Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, Kolkata, India.

出版信息

Parasite Immunol. 2021 Jan;43(1):e12783. doi: 10.1111/pim.12783. Epub 2020 Aug 27.

DOI:10.1111/pim.12783
PMID:32734677
Abstract

AIM

Leishmania donovani, the causative agent for visceral leishmaniasis (VL), modulates host monocytes/macrophages to ensure its survival. However, knowledge regarding the host-parasite interactions underpinning the disease remains limited. As disease progression is associated with polarization of monocytes/macrophages towards M2, which is regulated by cytokines IL-4/IL-13 and IL-10, this study evaluated the status of key IL-4- and IL-10 driven markers in experimental models of VL, as also evaluated their correlation, if any, with parasite load.

METHODS

In liver and splenic tissues from L donovani-infected hamsters and BALB/c mice, the parasite burden was determined along with mRNA expression of IL-4-driven markers, that is CD206, Arginase-I, CCL17, CCL22, PPAR-γ, STAT6, KLF4, FIZZ1 and YM1 along with IL-10-driven markers, CXCL13, IL-10, TGF-β, VDR, CCR2 and CYP27A1.

RESULTS

The mRNA expression of IL-4- and IL-10-driven markers was enhanced in both models, but only in the hamster model, the splenic tissues demonstrated a positive correlation between all the IL-10-driven markers and parasite load.

CONCLUSIONS

Contrary to human VL, both models demonstrated an increased expression of IL-4- and IL-10-driven markers.

摘要

目的

利什曼原虫(Leishmania donovani)是内脏利什曼病(VL)的病原体,它可调节宿主单核细胞/巨噬细胞以确保其存活。然而,与疾病相关的宿主-寄生虫相互作用的知识仍然有限。由于疾病的进展与单核细胞/巨噬细胞向 M2 极化有关,而 M2 是由细胞因子 IL-4/IL-13 和 IL-10 调节的,因此本研究评估了在 VL 的实验模型中关键的 IL-4 和 IL-10 驱动标志物的状态,并评估了它们与寄生虫负荷的任何相关性。

方法

在感染利什曼原虫的仓鼠和 BALB/c 小鼠的肝和脾组织中,测定寄生虫负荷以及 IL-4 驱动标志物的 mRNA 表达,即 CD206、精氨酸酶-I、CCL17、CCL22、PPAR-γ、STAT6、KLF4、FIZZ1 和 YM1,以及 IL-10 驱动标志物,即 CXCL13、IL-10、TGF-β、VDR、CCR2 和 CYP27A1。

结果

两种模型中 IL-4 和 IL-10 驱动标志物的 mRNA 表达均增强,但仅在仓鼠模型中,脾组织中所有 IL-10 驱动标志物与寄生虫负荷之间存在正相关。

结论

与人类 VL 相反,两种模型均表现出 IL-4 和 IL-10 驱动标志物的表达增加。

相似文献

1
Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.白细胞介素-4 和白细胞介素-10 驱动标志物在内脏利什曼病实验模型中的状态。
Parasite Immunol. 2021 Jan;43(1):e12783. doi: 10.1111/pim.12783. Epub 2020 Aug 27.
2
An IL-10 dominant polarization of monocytes is a feature of Indian Visceral Leishmaniasis.单核细胞的白细胞介素-10主导极化是印度内脏利什曼病的一个特征。
Parasite Immunol. 2018 Jul;40(7):e12535. doi: 10.1111/pim.12535. Epub 2018 May 30.
3
Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.进行性内脏利什曼病是由优势寄生虫诱导的 STAT6 激活和 STAT6 依赖性宿主精氨酸酶 1 表达驱动的。
PLoS Pathog. 2012 Jan;8(1):e1002417. doi: 10.1371/journal.ppat.1002417. Epub 2012 Jan 19.
4
Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.实验性内脏利什曼病中的转录谱分析揭示了广泛的脾脏炎症环境,该环境使巨噬细胞趋向于促疾病表型。
PLoS Pathog. 2017 Jan 31;13(1):e1006165. doi: 10.1371/journal.ppat.1006165. eCollection 2017 Jan.
5
The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.仓鼠作为人类内脏利什曼病的模型:面对显著的Th1样细胞因子反应时疾病进展及一氧化氮生成受损。
J Immunol. 2001 Feb 1;166(3):1912-20. doi: 10.4049/jimmunol.166.3.1912.
6
15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.15d-前列腺素J2在实验性内脏利什曼病期间诱导活性氧介导的细胞凋亡。
J Mol Med (Berl). 2016 Jun;94(6):695-710. doi: 10.1007/s00109-016-1384-5. Epub 2016 Feb 1.
7
Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis.在进行性实验性内脏利什曼病中,生长因子和Th2细胞因子信号通路在信号转导和转录激活因子6(STAT6)处汇聚,以促进精氨酸酶表达。
PLoS Pathog. 2014 Jun 26;10(6):e1004165. doi: 10.1371/journal.ppat.1004165. eCollection 2014 Jun.
8
Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host.利用金黄仓鼠模型实时成像内脏利什曼病:监测寄生虫负荷和仓鼠转录本以进一步表征宿主的免疫反应。
Parasitol Int. 2017 Feb;66(1):933-939. doi: 10.1016/j.parint.2016.10.020. Epub 2016 Oct 26.
9
Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.丁香酚乳剂在实验性内脏利什曼病中的免疫治疗潜力
PLoS Negl Trop Dis. 2016 Oct 24;10(10):e0005011. doi: 10.1371/journal.pntd.0005011. eCollection 2016 Oct.
10
Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.针对杜氏利什曼原虫实验性皮肤或内脏感染的细胞免疫反应的区域差异。
Infect Immun. 1998 Jan;66(1):18-27. doi: 10.1128/IAI.66.1.18-27.1998.

引用本文的文献

1
Targeting macrophage phenotypes to prevent diseases caused by and infections.针对巨噬细胞表型以预防由[具体病原体]感染引起的疾病。 (你原文中“and”前后内容缺失,请补充完整以便准确翻译)
Front Immunol. 2025 Aug 7;16:1595954. doi: 10.3389/fimmu.2025.1595954. eCollection 2025.
2
Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles.利什曼病中巨噬细胞的靶向和激活。聚焦氧化铁纳米颗粒。
Front Immunol. 2024 Aug 15;15:1437430. doi: 10.3389/fimmu.2024.1437430. eCollection 2024.
3
Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host-Pathogen Dynamics.
探索细菌感染中的免疫氧化还原调节:硫氧还蛋白介导的相互作用及对理解宿主-病原体动态的启示
Antioxidants (Basel). 2024 Apr 29;13(5):545. doi: 10.3390/antiox13050545.
4
Factors associated with survival in patients with visceral leishmaniasis treated at a reference hospital in northern Minas Gerais - Brazil.巴西米纳斯吉拉斯州北部一家参考医院治疗内脏利什曼病患者的生存相关因素。
Rev Soc Bras Med Trop. 2024 Feb 23;57:e004012024. doi: 10.1590/0037-8682-0045-2024. eCollection 2024.
5
Unwinding the mechanism of macrophage repolarization potential of sp. -derived protein protease inhibitor through Toll-like receptor 4 against experimental visceral leishmaniasis.通过 Toll 样受体 4 对抗实验内脏利什曼病,解析 sp. 衍生蛋白蛋白酶抑制剂对巨噬细胞再极化潜能的作用机制。
Front Cell Infect Microbiol. 2023 Mar 22;13:1120888. doi: 10.3389/fcimb.2023.1120888. eCollection 2023.
6
Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.过氧化物酶体增殖物激活受体靶向治疗:感染性疾病面临的挑战。
Cells. 2023 Feb 17;12(4):650. doi: 10.3390/cells12040650.
7
T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis.人内脏利什曼病和实验性内脏利什曼病中的 T 淋巴细胞耗竭。
Front Immunol. 2022 May 2;13:835711. doi: 10.3389/fimmu.2022.835711. eCollection 2022.
8
Quantitative monitoring of experimental and human leishmaniasis employing amastigote-specific genes.采用无鞭毛体特异性基因对实验性和人体利什曼病进行定量监测。
Parasitology. 2022 Jul;149(8):1085-1093. doi: 10.1017/S0031182022000610. Epub 2022 May 10.
9
Heterologous vaccine therapy associated with half course of Miltefosine promote activation of the proinflammatory response with control of splenic parasitism in a hamster model of visceral leishmaniasis.在仓鼠内脏利什曼病模型中,与半疗程米替福新联合使用的异源疫苗疗法可促进促炎反应的激活并控制脾脏寄生虫感染。
Curr Res Immunol. 2021 Nov 5;2:194-201. doi: 10.1016/j.crimmu.2021.10.003. eCollection 2021.
10
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.内脏利什曼病的免疫化学疗法:米替福新联合 LBSapMPL 疫苗的联合作用改善了适应性 Th1 免疫应答,控制了实验性仓鼠模型中的脾寄生。
Parasitology. 2022 Mar;149(3):371-379. doi: 10.1017/S0031182021001906. Epub 2021 Nov 2.